-
Study aim
-
The aim of this study was to evaluate the effects of lactulose and probiotics on the quality of life in cirrhotic patients.
-
Design
-
The present study is a clinical trial of phase 3, randomized, double-blind, and parallel, which will be performed on 80 patients with cirrhosis. Patients are randomly divided into two groups.
-
Settings and conduct
-
The Quality of Life Questionnaire for Chronic Hepatic Patients (CLDQ), which is based on the patient's symptoms and feelings from 1 to 7, as well as demographic information, will be obtained from the patients. this study will be conducted in the gastroenterology clinic, imam hospital, Ahvaz.
Patients are randomized to receive lactulose alone and probiotic lactulose in a group of 40.
-
Participants/Inclusion and exclusion criteria
-
patients with cirrhosis for any reason, age above 18.
exclusion criteria: History of other chronic diseases other than cirrhosis, History of chronic psychosomatic illness, moderate to severe encephalopathy, brain damage, active infection, active bleeding, acute renal failure, continuous use of occipital benzodiazepines, patient dissatisfaction and probiotic contraindications, such as the use of suppressive drugs or acute and severe infections.
-
Intervention groups
-
Patients with cirrhosis are randomly divided into two groups of 40 lactulose alone and probiotic plus lactulose.
-
Main outcome variables
-
Quality of life in patients with cirrhosis